Jasmohan Bajaj
@JasmohanBajaj
Followers
7K
Following
18K
Media
455
Statuses
3K
Liver specialist at Virginia Commonwealth University and Richmond VAMC . Interested in the brain liver gut axis. Co-EIC of Am J Gastro. Tweets are personal.
Richmond, VA
Joined December 2015
@PSCPartnersCa @BASLedu @BritSocGastro @BSGTrainees @LiverTrust @analleo @CholestasisDoc @AASLDtweets @ebtapper @rabataller @JasmohanBajaj @EmmaCulver6 @tom_marjot @OTavabie @PSCSupportUK @TheBileDoc @MichaelHenegha8 @tomhemmingk To coincide with PSC Awareness Day 29th October
The EASL Studio is back! Join experts @DebbieShawcros1, @DrCynthiaLevy, Stephen Rossi, and Michael Trauner this Wednesday 18:00 CET to learn more about endpoints, safety, and where they might fit in the care pathway for PSC patients. Read more: https://t.co/3xkKNUZmw3
0
3
9
1
8
57
We are honored to share our first Pakistan Endoscopy Atlas with the esteemed Professor @JasmohanBajaj, a guru of Hepatic Encephalopathy. Your dedication inspires us all, and we hope this contribution benefits many. #ACG2025 #WomenInGI
1
6
31
@AmCollegeGastro getting published @brianjacobsonmd @MLongMD @JasmohanBajaj @DaniyalAbbasMD @DushDahiya #GITwitter ✅Start with a review article or case report & you may find out it’s not for you ✅Find someone who publishes a lot ✅ Publishing shows commitment to the project
0
5
14
Good Morning, Phoenix #ACG2025🌵 Grab your ☕️ and let's go! 🥊 @AmCollegeGastro Post Graduate Course, Co Directors @ibdtweets @LindaNguyenMD 👏🏻 A spectacular agenda - Research to Reality: Enriching Clinical Practice 🎬 Starts 7:55 AM sharp in the North Ballroom! 📸 JosR
5
10
82
🪔On this auspicious occasion of Diwali We are thrilled to announce the Bengal Liver Summit 2026! 📅 8–10 January 2026 📍 ITC Royal Bengal, Kolkata 🎯 Theme: Acute Complications in Liver Disease 🌍 12 International 🇮🇳 100+ National Faculties Stay tuned for more updates! #BLS2026
2
8
23
Thanks for the invite @AasmaShaukatMD @AdamFayeMD @SunandaKaneMD to write the #liver section w Dr Wilson. @AmJGastro read for #MASH #Dementia #hepaticencephalopathy #HCC frailty & other topics important when managing seniors w liver disease! @VCU_Liver @VAResearch
NEW! ACG Monograph on Geriatrics & GI Topics include colonic conditions, IBD, vaccinations, "functional" GI disorders, pancreatic diseases, hepatobiliary disorders, and gastroesophageal conditions. 📕 https://t.co/Q179I86rbZ Editors: @AdamFayeMD @SunandaKaneMD @AasmaShaukatMD
1
3
23
Explore the October issue of the Red Journal! (Great in-flight reading on your way to #ACG2025 ✈️) 📕 https://t.co/0M4HCpiML3
@MLongMD @JasmohanBajaj @AndrewMMoon @TrieuMD
0
4
17
This is going to be a great debate! This is an EASL Studio not to be missed!#livertwitter @ef_clif @MicrobPredict @JonelTrebicka @JasmohanBajaj @BavenoCoop @AleksanderKrag @Inst_of_Liver @KingsCollegeNHS @vtkronsten @drmarkmcphail @TasPirani @LiverTrust @BSGTrainees @BASLedu
@MajaThiele @briantleemd @MzamoMbelle @PoseElisa @rabataller @AleksanderKrag Next week: Prognostic scores, multiple definitions, urgent transplants. Does the ACLF concept help or hinder care?🤔 #EASLStudio tackles what truly matters at the bedside. 📅Wednesday, 8 October | 18:00 CEST 🔗 https://t.co/Ewd8THCY80
@tom_marjot @ProfPaoloAngeli @BavenoCoop
0
6
33
🙏 Dr DNReddy @AnandVKulkarni2 @gvraoaig @AIGHospitals for the invite to participate in their #liverconclave2025. 2 days of hectic but wonderful learning and friendship with global colleagues! @ggarciatsao @ArunJSanyalVCU @ebtapper. Of course a break to visit Hampi was 💯!
0
5
40
Thanks @drbobbybrown for inviting us! Pleasure to write this with our ⭐️ fellow @vinayjaha @VCU_Liver @VAResearch @VCUHealth @BavenoCoop
Have you ever wondered if a disease-agnostic agent could slow down progression of cirrhosis? 📉 💊 From beta-blockers ⬇️ portal pressure to albumin stabilizing hemodynamics 🌊 🦠 rifaximin reshaping the gut-liver axis, and statins tackling inflammation Check out our 📖
1
0
22
Electronic Interventions to Improve Quality for Inpatient Cirrhosis Care: A Prospective Evaluation Romain, et al. 📕 https://t.co/ZYeCzVEuqx
@ebtapper @MLongMD @JasmohanBajaj
journals.lww.com
s caring for patients with cirrhosis and acute variceal hemorrhage or spontaneous bacterial peritonitis. RESULTS: Our BPAs increased utilization. Ceftriaxone use was associated with adverse outcomes...
0
5
16
Don’t forget the mouth➡️ role of 🦠 w cancers of upper GI tract @AmCollegeGastro @AmJGastro
Oral Microbiome Dysbiosis Is Associated With Precancerous Lesions and Disorders of Upper Gastrointestinal Tract: A Population-Based Study Sadeghi & Sohrabi, et al. 📕 https://t.co/nlAIIosuoC
@Prof_NickTalley @MLongMD @JasmohanBajaj
0
1
7
A Practical Guide to Diet and IBD Figueroa, et al. 📕 https://t.co/pqFKHsGOEV
@preethivenkatmd @GIdietitian @IBDMD @JamesLewisGIEpi @MLongMD @JasmohanBajaj
0
12
39
Prospective Controlled Study of Endoscopic Botulinum Toxin Injection for Retrograde Cricopharyngeus Dysfunction: The Inability to Belch Syndrome Sanagapalli, et al. 📕 https://t.co/s6cY3aJvME
@MLongMD @JasmohanBajaj
1
13
34
Ultra-Processed Grains and Risk of Inflammatory Bowel Disease: Results from the Prospective Urban Rural Epidemiology (PURE) Study Narula, et al. 📕 https://t.co/G7jvFfOp2j
@NarulaNeeraj @ToYourHealth101 @marshllj @PaulMoayyedi @MLongMD @JasmohanBajaj
0
29
45
Intraductal Papillary Mucinous Neoplasm and Pancreatic Cancer: Opportunity Knocks Twice Hamada, et al. 📕 https://t.co/dWiZG9vIly
@YousukeNak54193 @MLongMD @JasmohanBajaj
1
60
175
🚨 New @AmJGastro ACG Guideline 🚨 Pre-op risk assessment in chronic liver disease ▪️Assess for CSPH ▪️Use MELD & VOCALPenn for surgical risk ▪️Screen for HCC & EV ▪️>15% 90d mortality → consider LT eval ▪️TIPS in select high-risk cases 🔗 https://t.co/p5JViI35vt
4
83
209
Move yourself to move your bowels! 💩 =📈 =🏃♀️🏊 exercise in #NHANES @AmCollegeGastro @AmJGastro @BMoshiree @MarkPimentelMD
Association of Leisure-Time Physical Activity Patterns With Constipation: Evidence From the National Health and Nutrition Examination Survey Yang, et al. 📕 https://t.co/OegWpw7GlN
@MLongMD @JasmohanBajaj
1
11
29
Potential missed opportunities to improve long-term liver allograft health https://t.co/i33LRI2fYR
journals.lww.com
macologic interventions and medications currently in clinical trials for other disease processes—including hydroxymethylglutaryl-coenzyme A reductase inhibitors, aspirin, obesity and metabolic...
2
7
15